Standards bei der oberen gastrointestinalen Ulkusblutung

Literatur

• 1 Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz M B, Hawkey C J, Hochberg M C, Kvien T K, Schnitzer T J;. VIGOR Study Group . Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.  N Engl J Med. 2000;  343 1520-1528
• 2 Chan F K, Chung S C, Suen B Y, Lee Y T, Leung W K, Leung V K, Wu J C, Lau J Y, Hui Y, Lai M S, Chan H L, Sung J J. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.  N Engl J Med. 2001;  344 967-973
• 3 Chan F K, Hung L C, Suen B Y, Wu J C, Lee K C, Leung V K, Hui A J, To K F, Leung W K, Wong V W, Chung S C, Sung J J. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.  Engl J Med. 2002;  347 2104-2110
• 4 Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A. Canadian Critical Care Trials Group . A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation.  N Engl J Med. 1998;  338 791-797
• 5 Driks M R, Craven D E, Celli B R, Manning M, Burke R A, Garvin G M, Kunches L M, Farber H W, Wedel S A, McCabe W R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.  N Engl J Med. 1987;  317 1376-1382
• 6 Ell C, Hagenmüller F, Schmitt W, Riemann J F, Hahn E G, Hohenberger W. Multicenter prospective study of the current status of treatment for bleeding ulcer in Germany.  Dtsch Med Wochenschr. 1995;  120 3-9
• 7 Halm U, Halm F, Thein D, Mohr F W, Mössner J. Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery?.  Crit Care Med. 2000;  28 110-3
• 8 Jensen D M, Cheng S, Kovacs T O, Randall G, Jensen M E, Reedy T, Frankl H, Machicado G, Smith J, Silpa M. et al . A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.  N Engl J Med. 1994;  330 382-386
• 9 Khuroo M S, Yattoo G N, Javid G, Khan B A, Shah A A, Gulzar G M, Sodi J S. A comparison of omeprazole and placebo for bleeding peptic ulcer.  New Engl J Med. 1997;  336 1054-1058
• 10 Kohler B, Maier M, Benz C, Riemann J F. Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy.  Dig Dis Sci. 1997;  42 1370-1374
• 11 Lau J Y, Sung J J, Lam Y H, Chan A C, Ng E K, Lee D W, Chan F K, Suen R C, Chung S C. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers.  N Engl J Med. 1999;  340 751-756
• 12 Lau J Y, Sung J J, Lee K K, Yung M Y, Wong S K, Wu J C, Chan F K, Ng E K, You J H, Lee C W, Chan A C, Chung S C. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.  N Engl J Med. 2000;  343 310-316
• 13 Lin H J, Lo W C, Lee F Y, Perng C L, Tseng G Y. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.  Arch Intern Med. 1998;  158 54-58
• 14 Marmo R, Rotondano G, Bianco M A, Piscopo R, Prisco A, Cipolletta L. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis.  Gastrointest Endosc. 2003;  57 62-67
• 15 Messmann H, Schaller P, Andus T, Lock G, Vogt W, Gross V, Zirngibl H, Wiedmann K H, Lingenfelser T, Bauch K, Leser H G, Schölmerich J, Holstege A. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.  Endoscopy. 1998;  30 583-589
• 16 Silverstein F E, Graham D Y, Senior J R, Davies H W, Struthers B J, Bittman R M, Geis G S. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 1995;  123 241-249